Cystic fibrosis (CF) is a potentially fatal monogenic disease that causes a progressive multisystemic pathology. Over the last decade, the introduction of CF transmembrane conductance regulator (CFTR) modulator drugs into clinical practice has profoundly modified the lives of many people with CF (PwCF) by targeting the fundamental cause of the disease. These drugs consist of the potentiator ivacaftor (VX-770) and the correctors lumacaftor (VX-809), tezacaftor (VX-661), and elexacaftor (VX-445). In particular, the triple combination of CFTR modulators composed of elexacaftor, tezacaftor, and ivacaftor (ETI) represents a life-changing therapy for the majority of PwCF worldwide. A growing number of clinical studies have demonstrated the safety and efficacy of ETI therapy in both short- and long-term (up to two years of follow-up to date) and its ability to significantly reduce pulmonary and gastrointestinal manifestations, sweat chloride concentration, exocrine pancreatic dysfunction, and infertility/subfertility, among other disease signs and symptoms. Nevertheless, ETI therapy-related adverse effects have also been reported, and close monitoring by a multidisciplinary healthcare team remains vital. This review aims to address and discuss the major therapeutic benefits and adverse effects reported by the clinical use of ETI therapy for PwCF.
One of the requirements for the treatment of drinking water is the removal of pathogenic microorganisms. Typically, the most used techniques apply inorganic nanoparticles or chlorine release precursors to inactivate bacteria. While these treatments are very effective, they tend to show a decrease in antimicrobial activity over time, releasing potentially toxic ions and contributing to bacterial resistance. In this sense, the development of hydrogel-based materials has become a potential alternative for water disinfection. The synthesis and functionalization of hydrogels have been proven to improve the global performance of microorganism retention. Our work provides an overview of the synthesis and functionalization of hydrogel-based materials, their advantages and limitations, and the latest research on the use of hydrogels for water disinfection. The future panorama of hydrogel-based materials applicability for water treatment is also provided. The main challenge to expand the use of hydrogels in water treatment is the lack of research assessing the feasibility of large-scale applicability of these materials, considering real systems. Most of the studies carried out experiments at laboratory scale with controlled situations, in which interactions between microorganisms and real world contaminants were not considered.
15 November 2022 in Environmental Progress & Sustainable Energy
This work analyzes the production of a hydrogel composed of mucilage from the cactus Opuntia ficus-indica (OFI) and sodium alginate. In obtaining the new material, green synthesis was used, free of chemical compounds, and applied in the treatment of textile effluent for the adsorption of methylene blue (MB). The hydrogel was characterized by FT-IR, XRD, SEM, and zeta potential. The swelling study showed a maximum value of 262% at pH 6.0. Adsorption studies revealed a maximum adsorptive capacity of 7.21 mg g-1 in 400 min at 298 K. Furthermore, the experimental data showed better fit to the pseudo-second order and Langmuir models for kinetic and isothermal studies, respectively. The adsorptive process showed spontaneous and exothermic behavior as well as a chemisorptive nature. It is noteworthy that in the studies conducted at a higher concentration of the contaminant, the maximum adsorption was 760 mg g-1. The reuse of the hydrogel was effective for five cycles, maintaining the adsorption of approximately 50% MB removal. Therefore, the biodegradable hydrogel is a material that contributes to the environment, is low cost, with simple synthesis, and is a promising new material for large-scale applications, considering its sustainable character and high efficiency in the adsorption of MB in aqueous solution.